About
- - Company
    - About Sensus Healthcare
    - Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
      
      Read More
  - Patient Advocates
  - FAQ
    - - What is SRT?
        We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiation Therapy using the SRT-100™.
        
        Go to FAQ
      - What does SRT treat?
        The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
        
        Go to FAQ
      - Is SRT right for me?
        The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
        
        Go to FAQ
      - What should I expect?
        You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
        
        Go to FAQ
      - Is the SRT-100 safe?
        The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
        
        Go to FAQ
  - Careers
    - - Sensus - Field Service Engineer
    - View Career Opportunities
Physicians
Patients
Investors
- Corporate Governance Guidelines
- Code of Ethics and Business Conduct
Resources
Contact Us

SRT is Beneficial for Dermatology Practices & Patients More Than Ever!

SRT (Superficial Radiation Therapy) is a non-surgical treatment option for non-melanoma skin cancer patients. Patients 65 and older with comorbidities are deemed as bad surgical candidates and as a result, they are exploring non-surgical treatment options.

In a post COVID world, the standards for healthcare have changed.

More elderly patients with comorbidities are seeking non-surgical treatment options
Patients are concerned about infections now more than ever
With SRT there is rarely any wound care involved for patients
SRT eliminates the need for close quarters for Mohs patients waiting for results

SRT Provides a Solution for Patients Hesitant to Go Under the Knife

As skin cancer rates continue to rise, patients will continue to seek out non-surgical treatment options. In tough economic times when aesthetic and elective procedures might be challenging, the treatment of skin cancer continues to grow.

Often, non melanoma skin cancer is treated with Mohs Surgery. This procedure requires a lot of time in the office. And, as the name implies, it is a surgical procedure. SRT has a success rate of over 98%, and the benefits don't end there:

With SRT, patients are in and out of the office
There is a much lower risk of bacterial and viral transmission
Patients do not need to be in the waiting room for extended periods of time
There is no cutting, bleeding, stitching, or wound care involved.

SRT is a Solution for Doctors Too

As a doctor, you may be searching for ways to adapt your practice to our post-COVID "normal". SRT provides a solution for your patients to feel comfortable getting the skin cancer treatment they so desperately need. As a result, you will be able to treat more patients by offering superficial radiation therapy.

If you are a doctor or patient interested in finding out more about Superficial Radiation Therapy, please contact us today!

Start your journey to a happy & healthy recovery.